Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

2.53
-0.1400-5.24%
Post-market: 2.570.0399+1.58%19:21 EDT
Volume:4.16M
Turnover:10.47M
Market Cap:392.45M
PE:-3.91
High:2.70
Open:2.69
Low:2.44
Close:2.67
Loading ...

Humacyte Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
06 May

Humacyte Insiders Placed Bullish Bets Worth US$949.4k

Simply Wall St.
·
01 May

Benchmark Co. Keeps Their Buy Rating on Humacyte (HUMA)

TIPRANKS
·
31 Mar

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Mar

Humacyte price target lowered to $8 from $10 at BTIG

TipRanks
·
29 Mar

BTIG Adjusts Price Target on Humacyte to $8 From $10, Maintains Buy Rating

MT Newswires Live
·
28 Mar

Humacyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Humacyte Q4 2024 GAAP EPS $(0.16) Beats $(0.25) Estimate, Cash Balance Of $95.3M

Benzinga
·
28 Mar

BRIEF-Humacyte Q4 Operating Income USD -28.088 Million Vs. IBES Estimate USD -29.9 Million

Reuters
·
28 Mar

Press Release: Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Dow Jones
·
28 Mar

BUZZ-U.S. STOCKS ON THE MOVE-SurgePays, B. Riley, CarMax

Reuters
·
27 Mar

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
26 Mar

BRIEF-Humacyte To Present Fourth Quarter And Full Year Financial Results And Provide Corporate Update On March 28, 2025

Reuters
·
26 Mar

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

GlobeNewswire
·
26 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, GameStop, Humacyte

Reuters
·
26 Mar

BUZZ-Humacyte tumbles on pricing $50 mln stock offering

Reuters
·
26 Mar

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

Benzinga
·
26 Mar

Humacyte Prices $50 Million Stock Offering

MT Newswires Live
·
26 Mar

BRIEF-Humacyte Prices Public Offering Of 25 Million Shares At $2.00 Per Share

Reuters
·
26 Mar

Humacyte's Stock Drops Below 52-Week Low Amidst Share Sale

Dow Jones
·
26 Mar